The drug itself is not a cure-all, she says, noting that if you stop taking it your symptoms will likely come back
there are a lot of potential problems that they pose. What are GLP-1 drugs and why are they so costly
Specifically, tirzepatide prescriptions increased from 0.7% in 2022 to 2.8% in 2025, whereas semaglutide prescriptions decreased from 4.2% in 2022 to 2.1% in 2025
Sometimes they are having nausea, poor intake, constipation, weakness, or difficulty exercising
JAMA Intern Med 2024;184:1290-300.ArticlePubMedPMC 77
But radiologist Elizabeth McDonald at the University of Pennsylvania, who co-authored that study, says the protective effects with GLP-1s appear greater than with other treatments or lifestyle changes